News

Minaris Regenerative Medicine is proud to share current and past news and announcements from its over twenty years of experience. Please see below for our press releases and announcements.

    *This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, fomerly PCT or PCT Cell Therapy Services), apceth Biopharma GmbH, and Hitachi Chemical Co., Ltd. have been renamed Minaris Regenerative Medicine and are part of the Resonac Group.
    January 6, 2025

    Altaris Closes Acquisition of Minaris from Resonac (Japanese)

    Yokohama, Japan, Munich, Germany, and Allendale, New Jersey, USA. January 6, 2025. 2025年1月6日 Minaris Regeneraive Medicine株式会社 代表取締役社長 坂東 博人 レゾナックからAltarisへのMinaris株式譲渡完了について Altaris, LLC（以下 Altarisという）は2025年1月6日に株式会社レゾナック・ホールディングス（以下「レゾナック」という）の子会社であるMinaris Regenerative Medicine （米国のMinaris Regenerative Medicine, LLC、日本のMinaris Regenerative Medicine株式会社、ドイツのMinaris Regenerative Medicine ...
    January 6, 2025

    Altaris Closes Acquisition of Minaris from Resonac

    Yokohama, Japan, Munich, Germany, and Allendale, New Jersey, USA. January 6, 2025 Altaris, LLC (collectively with its managed funds, “Altaris”) announced today that it completed the acquisition of Minaris Regenerative Medicine (Minaris Regenerative Medicine, LLC in the United States, Minaris Regenerative Medicine Co., Ltd. in Japan, Minaris Regenerative Medicine GmbH in Germany, and along with ...
    All Posts

    Subscribe to Our Email Distribution List
    © 2025 Minaris Regenerative Medicine   |  Privacy Policy   |  Imprint